Renaissance Technologies »

Nektar Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2025-09-30 $16M 279k 56.90
2025-06-30 $6.4M 247k 25.84

More positions owned by Renaissance Technologies

Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Roblox Corp Cl A (RBLX)
United Therapeutics Corporation (UTHR)
Verisign (VRSN)
Applovin Corp Com Cl A (APP)
Microsoft Corporation (MSFT)
Kinross Gold Corp (KGC)
Exelixis (EXEL)
Franco-Nevada Corporation (FNV)
Alphabet Cap Stk Cl A (GOOGL)
Gilead Sciences (GILD)
Doordash Cl A (DASH)
Hims & Hers Health Com Cl A (HIMS)
Reddit Cl A (RDDT)

View all positions for Renaissance Technologies

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics